Package 70377-071-12

{"route": ["ORAL"], "spl_id": "7aa24558-b2a2-ed22-b6bc-69a011d2511a", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "unii": ["9HW64Q8G6G"], "rxcui": ["977427", "977434", "977438", "2056895"], "spl_set_id": ["435da284-ef0e-ca90-e0db-bab9382922e0"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Biocon Pharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70377-071-11)", "package_ndc": "70377-071-11", "marketing_start_date": "20250602"}, {"sample": false, "description": "6 BLISTER PACK in 1 CARTON (70377-071-12)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "70377-071-12", "marketing_start_date": "20250602"}], "brand_name": "Everolimus", "product_id": "70377-071_7aa24558-b2a2-ed22-b6bc-69a011d2511a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "70377-071", "generic_name": "everolimus", "labeler_name": "Biocon Pharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": ".75 mg/1"}], "application_number": "ANDA216140", "marketing_category": "ANDA", "marketing_start_date": "20250602", "listing_expiration_date": "20261231"}